好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2022 Annual Meeting Virtual Experience | PL5 - Frontiers in Neuroscience Plenary Session

Tuesday 04/26/22
10:00 AM - 12:30 PM EDT Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Plenary Session
Paul M. George, MD, PhD, MSE, FAAN
Aging, Dementia, and Behavioral Neurology, General Neurology, Infectious Disease, Multiple Sclerosis, Neuromuscular and Clinical Neurophysiology (EMG)
This plenary session features basic and translational research related to clinical issues of importance. Hear from four outstanding speakers as they summarize their recent research finding and dive into the clinical implications of the results.
2.50 CME credits

Program Materials Program Evaluations

Event Timeline
10:00 AM - 10:05 AM EDT Introduction Introduction
Paul M. George, MD, PhD, MSE, FAAN
10:05 AM - 10:30 AM EDT Speaker Roles of Astrocytes in CNS Inflammation
Francisco J. Quintana, PhD
10:30 AM - 10:35 AM EDT Introduction Introduction
Paul M. George, MD, PhD, MSE, FAAN
10:35 AM - 11:00 AM EDT Speaker Mapping the ALS Exposome: A Step Towards Prevention
Eva Feldman, MD, PhD, FAAN
11:00 AM - 11:05 AM EDT Introduction Introduction
Paul M. George, MD, PhD, MSE, FAAN
11:05 AM - 11:30 AM EDT Speaker Tau Protein as a Therapeutic Target and Biomarker for Neurological Disease
Adam L. Boxer, MD, PhD
11:30 AM - 11:35 AM EDT Introduction Introduction
Paul M. George, MD, PhD, MSE, FAAN
11:35 AM - 12:00 PM EDT Speaker Neurobiology of COVID-19
Robyn S. Klein, MD, PhD
12:00 PM - 12:30 PM EDT Q&A Fireside Chat
Francisco J. Quintana, PhD, Paul M. George, MD, PhD, MSE, FAAN, Robyn S. Klein, MD, PhD, Adam L. Boxer, MD, PhD, Eva Feldman, MD, PhD, FAAN
Faculty Disclosures
Eva Feldman, MD, PhD, FAAN The institution of Dr. Feldman has received research support from National Institutes of Health. The institution of Dr. Feldman has received research support from Centers for Disease Control and Prevention / Agency for Toxic Substances and Disease Registry. The institution of Dr. Feldman has received research support from Juvenile Diabetes Research Foundation. Dr. Feldman has received intellectual property interests from a discovery or technology relating to health care. Dr. Feldman has a non-compensated relationship as a Editorial Board Member with Journal of the Peripheral Nervous System, Experimental Neurology, Nature Neurology Reviews, Neurobiology of Disease, NeuroRx, Journal of Neurology Neurosurgery and Psychiatry, Scientific Reports, Lancet Neurology, Med (Cell Press Journal) that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Editor-in-Chief with Oxford University Press Contemporary Neurology Series that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Membership Committee Member, Strategic Planning Committee Member, and Chair of Section 07 with National Academy of Medicine that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Associate Editor with Annals of Neurology that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Governance Committee Chair with American Neurological Association that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Membership Committee Member, Strategic Planning Committee Member, Chair of Section 07, Neuroscience Forum, Council Member with National Academy of Medicine that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Committee on Making ALS a Livable Disease Member with National Academy of Sciences, Engineering, and Medicine that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Member, Blueprint Neurotherapeutics Network for Biologics (BPN-Biologics) External Oversight Committee with National Institutes of Health that is relevant to AAN interests or activities.
Adam L. Boxer, MD, PhD An immediate family member of Dr. Boxer has received personal compensation for serving as an employee of Kaiser Permanente. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono. Dr. Boxer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Oscotec. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Boxer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arrowhead. Dr. Boxer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine Biosciences. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Switch. Dr. Boxer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arvinas. Dr. Boxer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alector. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Boxer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Transposon. Dr. Boxer has stock in Alector. Dr. Boxer has stock in Arvinas. Dr. Boxer has stock in Neurovanda. The institution of Dr. Boxer has received research support from Biogen. The institution of Dr. Boxer has received research support from Eisai. The institution of Dr. Boxer has received research support from Regeneron. The institution of Dr. Boxer has received research support from NIH. The institution of Dr. Boxer has received research support from Bluefield Project. Dr. Boxer has received research support from Rainwater Charitable Foundation.
Francisco J. Quintana, PhD Dr. Quintana has nothing to disclose.
Paul M. George, MD, PhD, MSE, FAAN Dr. George has received personal compensation in the range of $0-$499 for serving as a Consultant for ConductiveBio. Dr. George has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Law firms. The institution of Dr. George has received research support from Conductive Bio. The institution of Dr. George has received research support from NIH. Dr. George has received intellectual property interests from a discovery or technology relating to health care. Dr. George has received personal compensation in the range of $5,000-$9,999 for serving as a Adjudicator with Baim Insititute. Dr. George has a non-compensated relationship as a Board Member with 好色先生 that is relevant to AAN interests or activities. Dr. George has a non-compensated relationship as a International Stroke Council Program committee member with American Heart Association that is relevant to AAN interests or activities.
Robyn S. Klein, MD, PhD No disclosure on file